indigo-carmine and Drug-Hypersensitivity

indigo-carmine has been researched along with Drug-Hypersensitivity* in 2 studies

Reviews

1 review(s) available for indigo-carmine and Drug-Hypersensitivity

Article	Year
A review of the specifications and toxicity of synthetic food colors permitted in Canada. CRC critical reviews in toxicology, 1979, Volume: 6, Issue:2 Topics: Amaranth Dye; Amaranthus; Animals; Azo Compounds; Canada; Drug Hypersensitivity; Drug Stability; Erythrosine; Food Analysis; Food Coloring Agents; Humans; Indigo Carmine; Naphthols; Sulfonic Acids; Tartrazine; Trityl Compounds	1979

Other Studies

1 other study(ies) available for indigo-carmine and Drug-Hypersensitivity

Article	Year
Blue dyes, blue people: the systemic effects of blue dyes when administered via different routes. Journal of clinical anesthesia, 2007, Volume: 19, Issue:4 We report 4 patients who had facial color changes to a blue-green-gray color and decreased oxygen saturation as measured by pulse oximetry. Patient 1 received an intravenous (IV) methylene blue solution during a urologic procedure, and the remaining three patients were administered subcutaneous indigo carmine (patient 2) or Patent Blue (Patients 3 and 4) for axillary lymph node mapping. All patients had above normal methemoglobin levels. Two (Patients 2 and 3) had hypotension, and one (Patient 3) required IV ephedrine to restore hemodynamic stability. Patient 4 had a hypersensitivity reaction characterized by systemic urticaria and blue-colored subintegumentary edema due to the subcutaneous administration. Topics: Aged; Cardiac Output; Color; Drug Hypersensitivity; Female; Humans; Indigo Carmine; Male; Methemoglobinemia; Methylene Blue; Middle Aged; Oxygen; Rosaniline Dyes; Skin	2007

Article

Year

Blue dyes, blue people: the systemic effects of blue dyes when administered via different routes.

Journal of clinical anesthesia, 2007, Volume: 19, Issue:4

We report 4 patients who had facial color changes to a blue-green-gray color and decreased oxygen saturation as measured by pulse oximetry. Patient 1 received an intravenous (IV) methylene blue solution during a urologic procedure, and the remaining three patients were administered subcutaneous indigo carmine (patient 2) or Patent Blue (Patients 3 and 4) for axillary lymph node mapping. All patients had above normal methemoglobin levels. Two (Patients 2 and 3) had hypotension, and one (Patient 3) required IV ephedrine to restore hemodynamic stability. Patient 4 had a hypersensitivity reaction characterized by systemic urticaria and blue-colored subintegumentary edema due to the subcutaneous administration.

Topics: Aged; Cardiac Output; Color; Drug Hypersensitivity; Female; Humans; Indigo Carmine; Male; Methemoglobinemia; Methylene Blue; Middle Aged; Oxygen; Rosaniline Dyes; Skin

2007